Schizophrenia and Disorders With Psychotic Features Clinical Trial
Official title:
Randomized Trial of Usual Care Versus Specialized, Phase-specific Care in the Public Sector for First Episode Psychosis.
The purpose of this study is to understand the effectiveness of a specialized package of phase-specific treatments for individuals in the midst of their first episode of psychosis. The pharmacologic and psychosocial treatments will be delivered within a state public mental health center.
We propose to conduct a clinical trial for first episode psychosis patients not eligible for CMHC services that will compare randomized access to care at CMHC versus the usual procedure of referral to community providers outside CMHC. Patients randomized to access to CMHC services will receive multifaceted, intensive, phase-specific care delivered by a specialized clinical team. This care will include five principal components: antipsychotic prescription, multi-family group therapy, group cognitive behavioral therapy, cognitive remediation and individual case management including supportive, problem solving approaches and a focus on resumption of movement towards educational and/or employment related goals. All consenting subjects will undergo research evaluations every six months for up to five years. Outcomes will be assessed in the domains of re-admission (primary outcome), relapse, symptoms, overall functioning, quality of life, education and employment, treatment satisfaction, adherence, substance use, adverse events (including self-harm) and economic measures including service use, cost of care and forensic data. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01196858 -
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland
|
N/A | |
Completed |
NCT00136760 -
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
|
Phase 2 | |
Completed |
NCT03309475 -
Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)
|
N/A | |
Not yet recruiting |
NCT01968161 -
Investigator Initiated Study - Asenapine Early Psychosis
|
Phase 4 | |
Completed |
NCT00135772 -
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
|
N/A | |
Completed |
NCT02308462 -
Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents
|
N/A | |
Completed |
NCT03133143 -
Video Games Among People With Schizophrenia
|
N/A | |
Not yet recruiting |
NCT02240173 -
Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
|
Phase 1/Phase 2 | |
Completed |
NCT00218218 -
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
|
Phase 2 | |
Completed |
NCT02321943 -
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
|
N/A | |
Completed |
NCT02928965 -
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
|
Phase 2 | |
Completed |
NCT02307396 -
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
|
Phase 4 | |
Terminated |
NCT00748566 -
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
|
Phase 4 | |
Recruiting |
NCT00791882 -
Social Skills Training in Refractory Schizophrenia
|
N/A | |
Completed |
NCT00363181 -
Side Effects of Antipsychotic Medications
|
||
Completed |
NCT00137189 -
Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation
|
N/A |